Jundishapur Journal of Microbiology

Published by: Kowsar

Occult Hepatitis B Infection in Patients With Cryptogenic Liver Cirrhosis in Southwest of Iran

Seyed Jalal Hashemi 1 , * , Eskandar Hajiani 2 , Abdolrahim Masjedizadeh 2 , Manoochehr Makvandi 1 , Ali Akbar Shayesteh 2 , Seyed Pejman Alavinejad 2 , Ahmad Kadkhodaei 2 , Heshmatollah Shahbazian 2 , Farzad Jasemi 2 and Mohamad Karimi 2
Authors Information
1 Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Research Institute for Infectious Disease of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2015, 8 (3); e16873
  • Published Online: March 21, 2015
  • Article Type: Research Article
  • Received: January 3, 2014
  • Revised: April 30, 2014
  • Accepted: May 10, 2014
  • DOI: 10.5812/jjm.16873

To Cite: Hashemi S J, Hajiani E, Masjedizadeh A, Makvandi M, Shayesteh A A, et al. Occult Hepatitis B Infection in Patients With Cryptogenic Liver Cirrhosis in Southwest of Iran, Jundishapur J Microbiol. 2015 ; 8(3):e16873. doi: 10.5812/jjm.16873.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337(24): 1733-45[DOI][PubMed]
  • 2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[PubMed]
  • 3. Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris). 2010; 58(4): 273-7[DOI][PubMed]
  • 4. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 5. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med. 2000; 3(4): 192-201
  • 6. Loriot MA, Marcellin P, Bismuth E, Martinot-Peignoux M, Boyer N, Degott C, et al. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. Hepatology. 1992; 15(1): 32-6[PubMed]
  • 7. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002; 2(8): 479-86
  • 8. Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology. 2001; 34(1): 204-6[DOI][PubMed]
  • 9. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007; 46(1): 160-70[DOI][PubMed]
  • 10. Rodriguez-Inigo E, Bartolome J, Ortiz-Movilla N, Platero C, Lopez-Alcorocho JM, Pardo M, et al. Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection. J Virol. 2005; 79(24): 15578-81[DOI][PubMed]
  • 11. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol. 2001; 34(3): 447-54[PubMed]
  • 12. Minuk GY, Sun DF, Greenberg R, Zhang M, Hawkins K, Uhanova J, et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology. 2004; 40(5): 1072-7[DOI][PubMed]
  • 13. Tramuto F, Maida CM, Colomba GM, Di Carlo P, Vitale F. Prevalence of occult hepatitis B virus infection in a cohort of HIV-positive patients resident in Sicily, Italy. Biomed Res Int. 2013; 2013: 859583[DOI][PubMed]
  • 14. Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, et al. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Korean J Hepatol. 2008; 14(1): 67-76[DOI][PubMed]
  • 15. Nishikawa H, Osaki Y. Clinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis. J Cancer. 2013; 4(6): 473-80[DOI][PubMed]
  • 16. Kitab B, Ezzikouri S, Alaoui R, Nadir S, Badre W, Trepo C, et al. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma. Liver Int. 2014; 34(6)-50[DOI][PubMed]
  • 17. Huang X, Hollinger FB. Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review. J Viral Hepat. 2014; 21(3): 153-62[DOI][PubMed]
  • 18. Berasain C, Betes M, Panizo A, Ruiz J, Herrero JI, Civeira MP, et al. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut. 2000; 47(3): 429-35[PubMed]
  • 19. Kaviani MJ, Behbahani B, Mosallaii MJ, Sari-Aslani F, Taghavi SA. Occult hepatitis B virus infection and cryptogenic chronic hepatitis in an area with intermediate prevalence of HBV infection. World J Gastroenterol. 2006; 12(31): 5048-50[PubMed]
  • 20. Agarwal N, Naik S, Aggarwal R, Singh H, Somani SK, Kini D, et al. Occult hepatitis B virus infection as a cause of cirrhosis of liver in a region with intermediate endemicity. Indian J Gastroenterol. 2003; 22(4): 127-31[PubMed]
  • 21. Anvari FA, Alavian SM, Norouzi M, Mahabadi M, Jazayeri SM. Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran. Oman Med J. 2014; 29(2): 92-6[DOI][PubMed]
  • 22. Ocana S, Casas ML, Buhigas I, Lledo JL. Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol. 2011; 17(12): 1553-7[DOI][PubMed]
  • 23. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008; 49(4): 652-7[DOI][PubMed]
  • 24. Vincenti D, Solmone M, Garbuglia AR, Iacomi F, Capobianchi MR. A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations. J Virol Methods. 2009; 159(1): 53-7[DOI][PubMed]
  • 25. Honarkar Z, Alavian SM, Samiee S, Saeedfar K, Zali MR. Occult hepatitis B among chronic liver disease patients. Saudi Med J. 2005; 26(4): 601-6[PubMed]
  • 26. Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010; 4(10): 658-61[PubMed]
  • 27. Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, et al. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Int J Infect Dis. 2010; 14(4)-10[DOI][PubMed]
  • 28. Heringlake S, Schutte A, Flemming P, Schmiegel W, Manns MP, Tillmann HL. Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology. Z Gastroenterol. 2009; 47(5): 417-23[DOI][PubMed]
  • 29. Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, et al. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect. 2009; 58(5): 383-8[DOI][PubMed]
  • 30. Song EY, Yun YM, Park MH, Seo DH. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology. 2009; 52(2): 57-62[DOI][PubMed]
  • 31. Pinarbasi B, Onel D, Cosan F, Akyuz F, Dirlik N, Cakaloglu Y, et al. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey. Liver Int. 2009; 29(2): 227-30[DOI][PubMed]
  • 32. Lin CL, Liu CJ, Chen PJ, Lai MY, Chen DS, Kao JH. High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users. J Med Virol. 2007; 79(11): 1674-8[DOI][PubMed]
  • 33. He J, Wu J, Du S. [Nested polymerase chain reaction (PCR) and multiple cloned antibody capture PCR for the examination of serum hepatitis B virus DNA in negative hepatitis B surface antigen patients suffering from liver diseases]. Zhonghua Nei Ke Za Zhi. 1996; 35(8): 537-41[PubMed]
  • 34. Blackberg J, Kidd-Ljunggren K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol. 2000; 33(6): 992-7[PubMed]
  • 35. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat. 1997; 4 Suppl 1: 11-20[PubMed]
  • 36. Zuckerman AJ. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet. 2000; 355(9213): 1382-4[DOI]
  • 37. Ackerman Z, Wands JR, Gazitt Y, Brechot C, Kew MC, Shouval D. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. J Hepatol. 1994; 20(3): 398-404[PubMed]
  • 38. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 2001; 34(1): 194-203[DOI][PubMed]
  • 39. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K, et al. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang. 2005; 88(2): 77-86[DOI][PubMed]
  • 40. Covolo L, Pollicino T, Raimondo G, Donato F. Occult hepatitis B virus and the risk for chronic liver disease: a meta-analysis. Dig Liver Dis. 2013; 45(3): 238-44[DOI][PubMed]
  • 41. Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, et al. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study. J Viral Hepat. 2009; 16(6): 437-43[DOI][PubMed]
  • 42. Vakili Ghartavol Z, Alavian SM, Amini S, Vahabpour R, Bahramali G, Mostafavi E, et al. Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran. Hepat Mon. 2013; 13(5)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments